Search
forResearch 10 of 848
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
- A Novel Secretory Vesicle from Deer Antlerogenic Mesenchymal Stem Cell-Conditioned Media (DaMSC-CM) Promotes Tissue Regeneration
- Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara<sup>®</sup>) and EE/LNG (Microgynon<sup>®</sup>)
- Profile of the progesterone derivative chlormadinone acetate — Pharmocodynamic properties and therapeutic applications
- Effects of two estroprogestins containing ethynilestradiol 30mug and drospirenone 3 mg and ethynilestradiol 30mug and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations
- Identification of novel hair‐growth inducers by means of connectivity mapping
- Cicatricial marginal alopecia: is it all traction?
- Preparation of Water Soluble Wool Keratin and Its Application for Human Hair
- Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers
- Bioequivalence study of generic finasteride in healthy male volunteers.
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →